Cubist Pharmaceuticals (CBST)

Add to Watchlists Create an Alert
56.11 +0.65  +1.17%   NASDAQ May 22, 8:00PM BATS Real time Currency in USD

Cubist Pharmaceuticals Liabilities:

890.69M for March 31, 2013
View Full Chart

Cubist Pharmaceuticals Liabilities Chart

    Cubist Pharmaceuticals Historical Liabilities Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 890.69M
    Dec. 31, 2012 941.64M
    Sept. 30, 2012 961.96M
    June 30, 2012 974.41M
    March 31, 2012 1.005B
    Dec. 31, 2011 1.088B
    Sept. 30, 2011 805.62M
    June 30, 2011 848.44M
    March 31, 2011 720.31M
    Dec. 31, 2010 751.73M
    Sept. 30, 2010 498.42M
    June 30, 2010 490.56M
    March 31, 2010 474.78M
    Dec. 31, 2009 513.04M
    Sept. 30, 2009 341.58M
    June 30, 2009 342.76M
    March 31, 2009 310.40M
    Dec. 31, 2008 336.81M
    Sept. 30, 2008 388.18M
    June 30, 2008 393.37M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Total Liabilities

    Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

    Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

    Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

    Simply, liabilities are the part of a company's assets that it has yet to repay back.
    Learn More

    Get data for

    CBST Liabilities Benchmarks

    Companies
    Optimer Pharmaceuticals 28.62M
    Celgene Corporation 5.898B
    Athersys 7.356M

    CBST Liabilities Rankings

    Overall 55th percentile
    3538 of 8005
    Sector 20th percentile
    545 of 686 in Healthcare
    Industry 13th percentile
    215 of 248 in Biotechnology

    CBST Liabilities Range, Past 5 Years

    Minimum 310.40M Mar 2009
    Maximum 1.088B Dec 2011
    Average 653.85M